Evidence map›Paper›PMID 24124485›Full record

ArticlePloS one2013

Lactobacillus plantarum DK119 as a probiotic confers protection against influenza virus by modulating innate immunity.

Min-Kyung Park, Vu Ngo, Young-Man Kwon, Young-Tae Lee, Sieun Yoo, Young-Hee Cho, Sung-Moon Hong, Hye Suk Hwang, Eun-Ju Ko, Yu-Jin Jung and 8 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed, 2 pooled it
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 2 syntheses or guidelines pooled it, 172 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Nutrients · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Frontiers in cellular and infection microbiology · 2025
    Article
  9. Nasal delivery of killedFrontiers in immunology · 2025
    Article
  10. Review
  11. Review
  12. Respiratory Delivery ofPharmaceutics · 2024
    Article
  13. Article
  14. Review
  15. Microorganisms · 2024
    Review
  16. Frontiers in immunology · 2024
    Article
  17. Article
  18. Review
  19. Review
  20. Review

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 2 countries.

Min-Kyung ParkDepartment of Human Nutrition and Food Science, Chungwoon University, Namjang-Ri, Hongsung-Eup, Hongsung-Kun, Chungnam, Korea ; Center for Inflammation, Immunity & Infection, and Department of Biology, Georgia State University, Atlanta, Georgia, United States of America.
Vu Ngo
Young-Man Kwon
Young-Tae Lee
Sieun Yoo
Young-Hee Cho
Sung-Moon Hong
Hye Suk Hwang
Eun-Ju Ko
Yu-Jin Jung
Dae-Won Moon
Eun-Ji Jeong
Min-Chul Kim
Yu-Na Lee
Ji-Hun Jang
Joon-Suk Oh
Cheol-Hyun Kim
Sang-Moo Kang
Georgia State University · USDankook University · KRChungwoon University · KR

Funding

Influenza vaccines inducing broadly cross protective immunityR01AI093772 · NIAID · GEORGIA STATE UNIVERSITY · PI KANG, SANG-MOO · 2011 to 2020
$4.2M
VLP Vaccine TechnologyR01AI105170 · NIAID · GEORGIA STATE UNIVERSITY · PI KANG, SANG-MOO · 2013 to 2017
$3.7M
Novel nanotechnology based oral influenza vaccinesR56AI087782 · NIAID · GEORGIA STATE UNIVERSITY · PI KANG, SANG-MOO · 2011 to 2011
$421k
NIAID NIH HHS AI087782NIAID NIH HHS AI093772NIAID NIH HHS AI105170NIAID NIH HHS R01 AI093772NIAID NIH HHS R01 AI105170NIAID NIH HHS R56 AI087782
6 · The paper itself

Abstract

Lactobacillus plantarum DK119 (DK119) isolated from the fermented Korean cabbage food was used as a probiotic to determine its antiviral effects on influenza virus. DK119 intranasal or oral administration conferred 100% protection against subsequent lethal infection with influenza A viruses, prevented significant weight loss, and lowered lung viral loads in a mouse model. The antiviral protective efficacy was observed in a dose and route dependent manner of DK119 administration. Mice that were treated with DK119 showed high levels of cytokines IL-12 and IFN-γ in bronchoalveolar lavage fluids, and a low degree of inflammation upon infection with influenza virus. Depletion of alveolar macrophage cells in lungs and bronchoalveolar lavages completely abrogated the DK119-mediated protection. Modulating host innate immunity of dendritic and macrophage cells, and cytokine production pattern appeared to be possible mechanisms by which DK119 exhibited antiviral effects on influenza virus infection. These results indicate that DK119 can be developed as a beneficial antiviral probiotic microorganism.

Indexed as

AnimalsBone Marrow CellsBronchoalveolar Lavage FluidDendritic CellsFemaleImmunity, InnateInfluenza A virusInterferon-gammaInterleukin-12Lactiplantibacillus plantarumMiceProbioticsInterferon-gammaInterleukin-12

Identifiers

PMID24124485
PMCPMC3790790
OpenAlexW2051988792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.